2025-09-09 - Analysis Report
Okay, here's a comprehensive analysis of Hims & Hers Health Inc. (HIMS), incorporating all the provided data points.

**Hims & Hers Health Inc. (HIMS) Analysis**

**Company Overview:** Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, offering personalized medical solutions.

**1. Performance vs. S&P 500 (VOO)**

*   **HIMS Cumulative Return:** 173.03%
*   **VOO Cumulative Return:** 67.60%
*   **Absolute Spread:** 103.1
*   **Relative Spread (0-100 scale):** 50.8

**Analysis:** HIMS has significantly outperformed the S&P 500 over the covered period. The relative spread of 50.8 suggests that HIMS's outperformance is around the median level compared to its historical range.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD   | Alpha   | Beta   | Cap(B) |
| ---------- | ------- | ----- | ------- | ------ | ------ |
| 2019-2021  | -46.0% | 51.0% | -83.0%  | 0.0    | 1.5    |
| 2020-2022  | -15.0% | 72.1% | -16.0%  | -0.0   | 1.5    |
| 2021-2023  | -51.0% | 72.1% | -69.0%  | -0.1   | 2.1    |
| 2022-2024  | 127.0% | 78.4% | 102.0%  | -0.1   | 5.6    |
| 2023-2025  | 168.0% | 80.7% | 116.0%  | -0.1   | 11.2   |

**Analysis:**

*   **CAGR:**  Volatile performance across different periods, with significant negative growth early on and strong positive growth in the later years.
*   **MDD:** High Maximum Drawdown (MDD) indicates significant risk and price volatility.
*   **Alpha:**  Negative Alpha in earlier periods indicates underperformance relative to the market. Positive Alpha in recent periods indicates strong outperformance.
*   **Beta:** Beta is generally around zero or slightly negative, suggesting the stock's price movements are not strongly correlated with the overall market.
*   **Market Cap:** Market Cap is growing.

**2. Recent Stock Price Movement**

*   **Current Price:** $48.41
*   **Last Market Data:** Price: $49.64, Previous Close: $48.41, Change: +2.54%
*   **5-day Moving Average:** $45.67
*   **20-day Moving Average:** $45.77
*   **60-day Moving Average:** $50.86

**Analysis:** The stock is trading above both its 5-day and 20-day moving averages, suggesting short-term bullish momentum. However, it is below its 60-day moving average, indicating potential resistance. The recent price jump of +2.54% suggests a possible breakout.

**3. Technical Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.33 (Low Risk)
*   **RSI:** 55.81 (Neutral)
*   **PPO:** 1.19 (Positive)
*   **Hybrid Signal:** cash_3%_Buy 80% of cash (473 shares - Caution - MRI:0.33)
*   **Recent (20-day) Relative Spread Change:** +1.6% (Short-term Increase)
*   **Expected Return (Long-Term):** -12.9% (vs. S&P 500)

**Analysis:**

*   The MRI suggests a low market risk environment for this stock.
*   The RSI is in a neutral zone, indicating neither overbought nor oversold conditions.
*   The PPO is positive, suggesting bullish momentum.
*   The Hybrid Signal suggests a cautious buying opportunity with a small cash reserve.
*   The 20-day relative spread increase indicates recent short-term outperformance.
*   The negative expected return suggests that, based on current conditions, the stock is expected to underperform the S&P 500 over the long term.

**4. Recent News & Significant Events (Yahoo Finance)**

*   **[2025-09-08] Hims & Hers Expanding Partnerships to Build a Global Health Ecosystem:**  Positive news suggesting growth and expansion potential.
*   **[2025-09-04] Hims & Hers (HIMS) Steals Spotlight as Court Junks Eli Lilly Lawsuit:**  A significant positive event, removing a potential legal overhang.
*   **[2025-09-04] Hims & Hers 'Personalized' Health Products Drove A 1,600% Share Price Increase In Less Than 4 Years:** Highlights the company's growth trajectory.
*   **[2025-09-04] Why Hims & Hers Health (HIMS) Stock Is Up Today:**  Provides insight into the reasons for recent stock price appreciation.
*   **[2025-09-03] Lyft convertible notes, Hims & Hers surges, Constellation Brands:**  Mentions HIMS in the context of market surges.
*   **[2025-09-03] Hims & Hers gains after court rejects Eli Lilly’s case against Willow:** Confirms the positive impact of the court ruling on the stock.

**Analysis:** Recent news is overwhelmingly positive, focusing on expansion, legal victories, and strong growth in share price. These events are likely contributing to the recent positive price movement.

**4-2. Analyst Opinions**

*   **Consensus:** Hold
*   **Mean Rating:** 2.75 (~Hold)
*   **Number of Opinions:** 11
*   **Target Price (Avg/High/Low):** $49.45 / $85.00 / $28.00

**Analysis:** Analyst consensus is currently a "Hold". The average target price of $49.45 is close to the current price. The wide range of target prices ($28.00 - $85.00) suggests significant disagreement among analysts about the stock's future potential.

**5. Recent Earnings Analysis**

| 날짜         | EPS  | 매출      |
| ------------ | ---- | --------- |
| 2025-08-04 | 0.19 | 0.54 B$  |
| 2025-05-05 | 0.22 | 0.59 B$  |
| 2024-11-04 | 0.35 | 0.40 B$  |
| 2024-08-05 | 0.06 | 0.32 B$  |
| 2025-08-04 | 0.06 | 0.32 B$  |

**Analysis:** EPS and revenue have been inconsistent. While revenue has generally increased, EPS has fluctuated. This could indicate challenges in maintaining profitability as the company grows.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
| ------------ | ------- | ------------- |
| 2025-06-30 | $0.54B | 76.39%       |
| 2025-03-31 | $0.59B | 73.50%       |
| 2024-12-31 | $0.48B | 76.81%       |
| 2024-09-30 | $0.40B | 79.16%       |
| 2024-06-30 | $0.32B | 81.30%       |

**Capital and Profitability:**

| Quarter      | Equity  | ROE     |
| ------------ | ------- | ------- |
| 2025-06-30 | $0.56B | 7.55%  |
| 2025-03-31 | $0.55B | 9.01%  |
| 2024-12-31 | $0.48B | 5.46%  |
| 2024-09-30 | $0.44B | 17.18% |
| 2024-06-30 | $0.36B | 3.67%  |

**Analysis:**

*   **Revenue:** Revenue is growing steadily quarter over quarter.
*   **Profit Margin:** Profit margins are high but show a slight downward trend.
*   **Equity:** Equity is increasing, indicating a strengthening financial position.
*   **ROE:** ROE has been volatile, with a significant peak in 2024-09-30, but has decreased since.

**7. Overall Summary**

Hims & Hers Health Inc. (HIMS) exhibits several key characteristics:

*   **High Growth Stock:**  Demonstrated by significant outperformance compared to the S&P 500, high revenue growth, and recent positive news.
*   **Volatile Performance:**  Evidenced by high MDD, fluctuating EPS, and ROE.
*   **Positive Momentum:** Supported by recent stock price movement, positive news events, and technical indicators like PPO.
*   **Mixed Analyst Sentiment:** Indicated by a consensus "Hold" rating and a wide range of target prices.
*   **Long-Term Uncertainty:** The negative expected return and inconsistent earnings suggest potential challenges in sustaining growth and profitability.

**Recommendation:**

Given the current data, a cautious approach is warranted. While the stock shows positive momentum and growth potential, the volatility and mixed analyst sentiment suggest that it may be risky. Investors should consider the high MDD and negative long-term expected return. A buy with a small allocation, as suggested by the Hybrid Signal, could be considered, but thorough due diligence and risk management are essential. Monitor future earnings reports and news closely to assess the company's ability to sustain growth and improve profitability.
